ShareValue scores for SXTC: Valuation 45, Quality 52, Growth 65, Health 48.

SXTC
NASDAQ

China SXT Pharmaceuticals Inc

$0.33(-83.53%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
45
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
65
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
71
Bullish
Price Trend

Company Details

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Score Analysis

AI Investment Thesis

Data as of:Jul 24, 2026
|
Last calculated:Jul 24, 2026